Physician profile

Mary L Barton

Psychiatric/Mental Health (Nurse Practitioner) · Du Bois, PA

NPI 1417426115

$603.44

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$19.98

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $204.54 2021-2022
Abbvie INC. $131.82 2021-2022
Glaxosmithkline, LLC. $120.00 2021
Otsuka America Pharmaceutical, INC. $53.97 2021
Neurocrine Biosciences, INC. $49.07 2021-2023 Ingrezza
Novartis Pharmaceuticals Corporation $18.76 2021
Lilly USA, LLC $12.96 2021
Lundbeck LLC $12.32 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mary L Barton

$603.44

in general payments reported 2019-2025

Years
2021-2023
Top company
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.)

https://glasscript.com/doctor/10497549/mary-l-barton

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.